OP30- Thyroidectomy Consent – A UK Study


    McIntyre, Charlotte1; Palazzo, Fausto1; Tolley, Neil
    1 Department of Endocrine and Thyroid Surgery, Imperial College Healthcare NHS Foundation Trust, St. Mary’s Hospital, London, UK


    Background: In 2015-16, the National Health Service (NHS) Litigation Authority received 10,965 claims for clinical negligence with Surgery having the highest number of claims.  Currently a sum amounting to 25% of the annual NHS budget has been ring-fenced to meet extant claims.  Claims made on a basis of inadequate informed consent are increasingly seen with many achieving a successful plaintiff outcome. There are presently no UK guidelines for Thyroidectomy consent. This study analyzed Thyroidectomy practice in 192 UK Surgeons.  All were British Association of Endocrine-Thyroid Surgeons (BAETS) members.

    Methods: An anonymised SurveyMonkey questionnaire was sent to all BAETS Surgeons.  Each selected from a list of complications those that they routinely consented patients for when performing: total thyroidectomy (Benign), total thyroidectomy (Cancer), hemi-thyroidectomy (no prior surgery) and a lateral selective neck dissection.

    Results: 192 questionnaires were analyzed from a range of surgical disciplines. 51% were ENT, 22% Endocrine, 16% General, 9% Breast and 2% Maxillofacial. 93% of surgeons perform benign and cancer surgery.

    For a total thyroidectomy (cancer), 99% consent for Recurrent Laryngeal Nerve (RLN) and voice change (temporary/permanent). 72% consent for External Laryngeal Nerve (ELN) injury. 51% consent for tracheostomy and 56% consent for risks of general anaesthetic and associated complications.

    Discussion and Conclusion: Wide variability was found in the consenting practice of Thyroid surgeons in the UK. A BAETS approved consensus guideline to standardise the UK practice of consent may help reduce future complaints and litigation claims.




Leave a Reply

  • Upcoming Events


    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts


  • WCTC3.5 Steering Committee:


    Rocco Bellantone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD